StockData
Amarin Corp PLC logo

Amarin Corp PLC (AMRN) stock

AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3061% above fair value
$11.27−0.04 (-0.35%)

Close on Nov 17, 2026Market cap $249.12MP/E –Yield –

Amarin cash

Cash and short-term investments held at the end of each period.

Amarin's cash was $323.38M at Sep 30, 2026. For fiscal 2025 it was $302.59M, up 2.8% from the year before. Over ten years it grew 11.0% a year on average. The highest annual figure on record is $644.59M in fiscal 2019.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$302.59M+2.8%
FY2024Dec 31, 2024$294.22M-8.2%
FY2023Dec 31, 2023$320.66M+3.7%
FY2022Dec 31, 2022$309.36M-31.9%
FY2021Dec 31, 2021$454.13M-9.3%
FY2020Dec 31, 2020$500.93M-22.3%
FY2019Dec 31, 2019$644.59M+158.6%
FY2018Dec 31, 2018$249.23M+238.5%
FY2017Dec 31, 2017$73.64M-25.5%
FY2016Dec 31, 2016$98.85M-7.6%
FY2015Dec 31, 2015$106.96M-10.5%
FY2014Dec 31, 2014$119.54M-37.6%
FY2013Dec 31, 2013$191.51M-26.4%
FY2012Dec 31, 2012$260.24M+123.2%
FY2011Dec 31, 2011$116.60M+270.8%
FY2010Dec 31, 2010$31.44M-39.8%
FY2009Dec 31, 2009$52.26M+267.0%
FY2008Dec 31, 2008$14.24M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$323.38M+12.8%
Q2 FY2026Jun 30, 2026$314.65M+5.3%
Q1 FY2026Mar 31, 2026$307.82M+9.2%
Q4 FY2025Dec 31, 2025$302.59M+2.8%
Q3 FY2025Sep 30, 2025$286.59M-6.3%
Q2 FY2025Jun 30, 2025$298.70M-2.6%
Q1 FY2025Mar 31, 2025$281.79M-8.6%
Q4 FY2024Dec 31, 2024$294.22M-8.2%
Q3 FY2024Sep 30, 2024$305.73M-4.7%
Q2 FY2024Jun 30, 2024$306.66M-2.0%
Q1 FY2024Mar 31, 2024$308.18M+1.3%
Q4 FY2023Dec 31, 2023$320.66M+3.7%
Q3 FY2023Sep 30, 2023$320.66M+5.6%
Q2 FY2023Jun 30, 2023$312.91M-0.1%
Q1 FY2023Mar 31, 2023$304.37M-16.0%
Q4 FY2022Dec 31, 2022$309.36M-31.9%
Q3 FY2022Sep 30, 2022$303.70M-36.6%
Q2 FY2022Jun 30, 2022$313.23M-38.5%
Q1 FY2022Mar 31, 2022$362.56M-29.6%
Q4 FY2021Dec 31, 2021$454.13M-9.3%
Q3 FY2021Sep 30, 2021$479.14M-14.7%
Q2 FY2021Jun 30, 2021$508.93M-7.5%
Q1 FY2021Mar 31, 2021$514.74M-5.1%
Q4 FY2020Dec 31, 2020$500.93M-22.3%
Q3 FY2020Sep 30, 2020$561.86M-16.5%
Q2 FY2020Jun 30, 2020$550.28M+148.1%
Q1 FY2020Mar 31, 2020$542.24M+156.9%
Q4 FY2019Dec 31, 2019$644.59M+158.6%
Q3 FY2019Sep 30, 2019$673.21M+722.1%
Q2 FY2019Jun 30, 2019$221.77M+116.9%
Q1 FY2019Mar 31, 2019$211.09M+63.6%
Q4 FY2018Dec 31, 2018$249.23M+238.5%
Q3 FY2018Sep 30, 2018$81.89M+3.5%
Q2 FY2018Jun 30, 2018$102.26M+19.6%
Q1 FY2018Mar 31, 2018$129.05M+33.5%
Q4 FY2017Dec 31, 2017$73.64M-25.5%
Q3 FY2017Sep 30, 2017$79.09M–
Q2 FY2017Jun 30, 2017$85.46M–
Q1 FY2017Mar 31, 2017$96.68M–
Q4 FY2016Dec 31, 2016$98.85M–

More Amarin figures

See a number that looks wrong?